-
BCH-BB694 Gene Therapy Safely Treating Severe SCD Patients in Pilot Trial
Interim Phase 1 trial data show BCH-BB694 safely increased fetal hemoglobin levels and prevented SCD complications in 6 patients with severe sickle cell. Read the full story here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.